Publications

• 1. Rahman SM
  2. Buchholz DW
  3. Imbiakha B
  4. Jager MC
  5. Leach J
  6. Osborn RM
  7. Birmingham AO
  8. Dewhurst S
  9. Aguilar HC
  10. Luebke AE
  Migraine inhibitor olcegepant reduces weight loss and IL-6 release in SARS-CoV-2-infected older mice with neurological signs.; Journal of virology. 2024 May 30.
• 1. Zand MS
  2. Spallina S
  3. Ross A
  4. Zandi K
  5. Pawlowski A
  6. Seplaki CL
  7. Herington J
  8. Corbett AM
  9. Kaukeinen K
  10. Holden-Wiltse J
  11. Freedman EG
  12. Alcantara L
  13. Li D
  14. Cameron A
  15. Beaumont N
  16. Dozier A
  17. Dewhurst S
  18. Foxe JJ
  Ventilation during COVID-19 in a school for students with intellectual and developmental disabilities (IDD).; PloS one; Vol 19(4), pp. e0291840. 2024 Apr 03.
• 1. Imbiakha B
  2. Sahler JM
  3. Buchholz DW
  4. Ezzatpour S
  5. Jager M
  6. Choi A
  7. Monreal IA
  8. Byun H
  9. Adeleke RA
  10. Leach J
  11. Whittaker G
  12. Dewhurst S
  13. Rudd BD
  14. Aguilar HC
  15. August A
  Adaptive immune cells are necessary for SARS-CoV-2-induced pathology.; Science advances; Vol 10(1), pp. eadg5461. 2024 Jan 03.
• 1. Zand MS
  2. Spallina S
  3. Ross A
  4. Zandi K
  5. Pawlowski A
  6. Seplaki CL
  7. Herington J
  8. Corbett AM
  9. Kaukeinen K
  10. Holden-Wiltse J
  11. Freedman EG
  12. Alcantara L
  13. Li D
  14. Cameron A
  15. Beaumont N
  16. Dozier A
  17. Dewhurst S
  18. Foxe JJ
  Ventilation during COVID-19 in a school for students with intellectual and developmental disabilities (IDD).; medRxiv : the preprint server for health sciences. 2023 Sep 10.
• 1. Schuster JE
  2. Erickson TR
  3. Goldman JL
  4. Benjamin DK
  5. Brookhart MA
  6. Dewhurst S
  7. Fist A
  8. Foxe J
  9. Godambe M
  10. Gwynn L
  11. Kiene SM
  12. Keener Mast D
  13. McDaniels-Davidson C
  14. Newland JG
  15. Oren E
  16. Selvarangan R
  17. Shinde N
  18. Walsh T
  19. Watterson T
  20. Zand M
  21. Zimmerman KO
  22. Kalu IC
  Utilization and Impact of Symptomatic and Exposure SARS-CoV-2 Testing in K-12 Schools.; Pediatrics; Vol 152(Suppl 1). 2023 Jul 01.
• 1. Goldman JL
  2. Kalu IC
  3. Schuster JE
  4. Erickson T
  5. Mast DK
  6. Zimmerman K
  7. Benjamin DK
  8. Kalb LG
  9. Gurnett C
  10. Newland JG
  11. Sherby M
  12. Godambe M
  13. Shinde N
  14. Watterson T
  15. Walsh T
  16. Foxe J
  17. Zand M
  18. Dewhurst S
  19. Coller R
  20. DeMuri GP
  21. Archuleta S
  22. Ko LK
  23. Inkelas M
  24. Manuel V
  25. Lee R
  26. Oh H
  27. Murugan V
  28. Kramer J
  29. Okihiro M
  30. Gwynn L
  31. Pulgaron E
  32. McCulloh R
  33. Broadhurst J
  34. McDaniels-Davidson C
  35. Kiene S
  36. Oren E
  37. Wu Y
  38. Wetter DW
  39. Stump T
  40. Brookhart MA
  41. Fist A
  42. Haroz E
  Building School-Academic Partnerships to Implement COVID-19 Testing in Underserved Populations.; Pediatrics; Vol 152(Suppl 1). 2023 Jul 01.
• 1. Zhou T
  2. Gilliam NJ
  3. Li S
  4. Spandau S
  5. Osborn RM
  6. Connor S
  7. Anderson CS
  8. Mariani TJ
  9. Thakar J
  10. Dewhurst S
  11. Mathews DH
  12. Huang L
  13. Sun Y
  Generation and Functional Analysis of Defective Viral Genomes during SARS-CoV-2 Infection.; mBio. 2023 Apr 19.
• 1. Osborn RM
  2. Leach J
  3. Zanche M
  4. Ashton JM
  5. Chu C
  6. Thakar J
  7. Dewhurst S
  8. Rosenberger S
  9. Pavelka M
  10. Pryhuber GS
  11. Mariani TJ
  12. Anderson CS
  Preparation of noninfectious scRNAseq samples from SARS-CoV-2-infected epithelial cells.; PloS one; Vol 18(2), pp. e0281898. 2023 Feb 24.
• 1. Molina Vargas AM
  2. Sinha S
  3. Osborn R
  4. Arantes PR
  5. Patel A
  6. Dewhurst S
  7. Hardy DJ
  8. Cameron A
  9. Palermo G
  10. O'Connell MR
  New design strategies for ultra-specific CRISPR-Cas13a-based RNA detection with single-nucleotide mismatch sensitivity.; Nucleic acids research. 2023 Jan 30.
• 1. Zhou T
  2. Gilliam NJ
  3. Li S
  4. Spaudau S
  5. Osborn RM
  6. Anderson CS
  7. Mariani TJ
  8. Thakar J
  9. Dewhurst S
  10. Mathews DH
  11. Huang L
  12. Sun Y
  Generation and functional analysis of defective viral genomes during SARS-CoV-2 infection.; bioRxiv : the preprint server for biology. 2022 Sep 23.
• 1. Nogales A
  2. Steel J
  3. Liu WC
  4. Lowen AC
  5. Rodriguez L
  6. Chiem K
  7. Cox A
  8. García-Sastre A
  9. Albrecht RA
  10. Dewhurst S
  11. Martínez-Sobrido L
  Mutation L319Q in the PB1 Polymerase Subunit Improves Attenuation of a Candidate Live-Attenuated Influenza A Virus Vaccine.; Microbiology spectrum. 2022 May 18.
• 1. Raymonda MH
  2. Ciesla JH
  3. Monaghan M
  4. Leach J
  5. Asantewaa G
  6. Smorodintsev-Schiller LA
  7. Lutz MM
  8. Schafer XL
  9. Takimoto T
  10. Dewhurst S
  11. Munger J
  12. Harris IS
  Pharmacologic profiling reveals lapatinib as a novel antiviral against SARS-CoV-2 in vitro.; Virology; Vol 566. 2021 Nov 27.
• 1. Sherby MR
  2. Kalb LG
  3. Coller RJ
  4. DeMuri GP
  5. Butteris S
  6. Foxe JJ
  7. Zand MS
  8. Freedman EG
  9. Dewhurst S
  10. Newland JG
  11. Gurnett CA
  Supporting COVID-19 School Safety for Children With Disabilities and Medical Complexity.; Pediatrics. 2021 Nov 04.
• 1. Chojnacki M
  2. Dobrotka C
  3. Osborn R
  4. Johnson W
  5. Young M
  6. Meyer B
  7. Laskey E
  8. Wozniak RAF
  9. Dewhurst S
  10. Dunman PM
  Evaluating the Antimicrobial Properties of Commercial Hand Sanitizers.; mSphere; Vol 6(2). 2021 Mar 03.
• 1. Cox A
  2. Schmierer J
  3. D'Angelo J
  4. Smith A
  5. Levenson D
  6. Treanor J
  7. Kim B
  8. Dewhurst S
  A Mutated PB1 Residue 319 Synergizes with the PB2 N265S Mutation of the Live Attenuated Influenza Vaccine to Convey Temperature Sensitivity.; Viruses; Vol 12(11). 2020 Oct 31.
• 1. Simpson SR
  2. Singh MV
  3. Dewhurst S
  4. Schifitto G
  5. Maggirwar SB
  Platelets function as an acute viral reservoir during HIV-1 infection by harboring virus and T-cell complex formation.; Blood advances; Vol 4(18). 2020 Sep 22.
• 1. Piekna-Przybylska D
  2. Bambara RA
  3. Maggirwar SB
  4. Dewhurst S
  G-quadruplex ligands targeting telomeres do not inhibit HIV promoter activity and cooperate with latency reversing agents in killing latently infected cells.; Cell cycle (Georgetown, Tex.). 2020 Aug 17.
• 1. Ma Q
  2. Schifitto G
  3. Venuto C
  4. Ocque A
  5. Dewhurst S
  6. Morse GD
  7. Aalinkeel R
  8. Schwartz SA
  9. Mahajan SD
  Effect of Dolutegravir and Sertraline on the Blood Brain Barrier (BBB).; Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology; Vol 15(1). 2020 Mar.
• 1. Smith A
  2. Rodriguez L
  3. Ghouayel ME
  4. Nogales A
  5. Chamberlain JM
  6. Sortino K
  7. Reilly E
  8. Feng C
  9. Topham DJ
  10. Martínez-Sobrido L
  11. Dewhurst S
  A live-attenuated influenza vaccine (LAIV) elicits enhanced heterologous protection when the internal genes of the vaccine are matched to the challenge virus.; Journal of virology. 2019 Nov 20.
• 1. Rodriguez L
  2. Blanco-Lobo P
  3. Reilly EC
  4. Maehigashi T
  5. Nogales A
  6. Smith A
  7. Topham DJ
  8. Dewhurst S
  9. Kim B
  10. Martínez-Sobrido L
  Comparative Study of the Temperature Sensitive, Cold Adapted and Attenuated Mutations Present in the Master Donor Viruses of the Two Commercial Human Live Attenuated Influenza Vaccines.; Viruses; Vol 11(10). 2019 Oct 10.
• 1. Chamberlain JM
  2. Sortino K
  3. Sethna P
  4. Bae A
  5. Lanier R
  6. Bambara RA
  7. Dewhurst S
  Cidofovir Diphosphate Inhibits Adenovirus 5 DNA Polymerase via both Nonobligate Chain Termination and Direct Inhibition, and Polymerase Mutations Confer Cidofovir Resistance on Intact Virus.; Antimicrobial agents and chemotherapy; Vol 63(1). 2019 Jan.
• 1. Mathew E
  2. Zhu H
  3. Connelly SM
  4. Sullivan MA
  5. Brewer MG
  6. Piepenbrink MS
  7. Kobie JJ
  8. Dewhurst S
  9. Dumont ME
  Display of the HIV envelope protein at the yeast cell surface for immunogen development.; PloS one; Vol 13(10). 2018.
• 1. Sheik DA
  2. Dewhurst S
  3. Yang J
  Natural Seminal Amyloids as Targets for Development of Synthetic Inhibitors of HIV Transmission.; Accounts of chemical research; Vol 50(9). 2017 Sep 19.
• 1. Hilimire TA
  2. Chamberlain JM
  3. Anokhina V
  4. Bennett RP
  5. Swart O
  6. Myers JR
  7. Ashton JM
  8. Stewart RA
  9. Featherston AL
  10. Gates K
  11. Helms ED
  12. Smith HC
  13. Dewhurst S
  14. Miller BL
  HIV-1 Frameshift RNA-Targeted Triazoles Inhibit Propagation of Replication-Competent and Multi-Drug-Resistant HIV in Human Cells.; ACS chemical biology. 2017 May 05.
• 1. Sheik DA
  2. Chamberlain JM
  3. Brooks L
  4. Clark M
  5. Kim YH
  6. Leriche G
  7. Kubiak CP
  8. Dewhurst S
  9. Yang J
  Hydrophobic Nanoparticles Reduce the β-Sheet Content of SEVI Amyloid Fibrils and Inhibit SEVI-Enhanced HIV Infectivity.; Langmuir : the ACS journal of surfaces and colloids; Vol 33(10). 2017 Mar 14.
• 1. Brewer MG
  2. DiPiazza A
  3. Acklin J
  4. Feng C
  5. Sant AJ
  6. Dewhurst S
  Nanoparticles decorated with viral antigens are more immunogenic at low surface density.; Vaccine; Vol 35(5). 2017 Feb 01.
• 1. Buckley G
  2. Smith S
  3. DeCaro J
  4. Barnett S
  5. Dewhurst S
  Building community for deaf scientists.; Science (New York, N.Y.); Vol 355(6322). 2017 Jan 20.
• 1. Mattiacio JL
  2. Brewer M
  3. Dewhurst S
  Display of HIV-1 Envelope Protein on Lambda Phage Scaffold as a Vaccine Platform.; Methods in molecular biology (Clifton, N.J.); Vol 1581. 2017.
• 1. Blanchard C
  2. Brooks L
  3. Ebsworth-Mojica K
  4. Didione L
  5. Wucher B
  6. Dewhurst S
  7. Krysan D
  8. Dunman PM
  9. Wozniak RA
  Zinc Pyrithione Improves the Antibacterial Activity of Silver Sulfadiazine Ointment.; mSphere; Vol 1(5). 2016 Sep.
• 1. Blanchard C
  2. Brooks L
  3. Beckley A
  4. Colquhoun J
  5. Dewhurst S
  6. Dunman PM
  Neomycin Sulfate Improves the Antimicrobial Activity of Mupirocin-Based Antibacterial Ointments.; Antimicrobial agents and chemotherapy; Vol 60(2). 2016 Feb.
• 1. Nishimura C
  2. Polesskaya O
  3. Dewhurst S
  4. Silva JN
  Quantification of Cerebral Vascular Architecture using Two-photon Microscopy in a Mouse Model of HIV-induced Neuroinflammation.; Journal of visualized experiments : JoVE. 2016.
• 1. Puccini JM
  2. Marker DF
  3. Fitzgerald T
  4. Barbieri J
  5. Kim CS
  6. Miller-Rhodes P
  7. Lu SM
  8. Dewhurst S
  9. Gelbard HA
  Leucine-rich repeat kinase 2 modulates neuroinflammation and neurotoxicity in models of human immunodeficiency virus 1-associated neurocognitive disorders.; The Journal of neuroscience : the official journal of the Society for Neuroscience; Vol 35(13). 2015 Apr 1.
• 1. Cox A
  2. Baker SF
  3. Nogales A
  4. Martínez-Sobrido L
  5. Dewhurst S
  Development of a mouse-adapted live attenuated influenza virus that permits in vivo analysis of enhancements to the safety of live attenuated influenza virus vaccine.; Journal of virology; Vol 89(6). 2015 Mar.
• 1. Sheik DA
  2. Brooks L
  3. Frantzen K
  4. Dewhurst S
  5. Yang J
  Inhibition of the enhancement of infection of human immunodeficiency virus by semen-derived enhancer of virus infection using amyloid-targeting polymeric nanoparticles.; ACS nano; Vol 9(2). 2015 Feb 24.
• 1. Cox A
  2. Dewhurst S
  A Single Mutation at PB1 Residue 319 Dramatically Increases the Safety of PR8 Live Attenuated Influenza Vaccine in a Murine Model without Compromising Vaccine Efficacy.; Journal of virology; Vol 90(5). 2015.
• 1. Ying B
  2. Tollefson AE
  3. Spencer JF
  4. Balakrishnan L
  5. Dewhurst S
  6. Capella C
  7. Buller RM
  8. Toth K
  9. Wold WS
  Ganciclovir inhibits human adenovirus replication and pathogenicity in permissive immunosuppressed Syrian hamsters.; Antimicrobial agents and chemotherapy; Vol 58(12). 2014 Dec.
• 1. Silva JN
  2. Polesskaya O
  3. Wei HS
  4. Rasheed IY
  5. Chamberlain JM
  6. Nishimura C
  7. Feng C
  8. Dewhurst S
  Chronic central nervous system expression of HIV-1 Tat leads to accelerated rarefaction of neocortical capillaries and loss of red blood cell velocity heterogeneity.; Microcirculation (New York, N.Y. : 1994); Vol 21(7). 2014 Oct.
• 1. Nogales A
  2. Baker SF
  3. Ortiz-Riaño E
  4. Dewhurst S
  5. Topham DJ
  6. Martínez-Sobrido L
  Influenza A virus attenuation by codon deoptimization of the NS gene for vaccine development.; Journal of virology; Vol 88(18). 2014 Sep.
• 1. Polesskaya O
  2. Wong C
  3. Lebron L
  4. Chamberlain JM
  5. Gelbard HA
  6. Goodfellow V
  7. Kim M
  8. Daiss JL
  9. Dewhurst S
  MLK3 regulates fMLP-stimulated neutrophil motility.; Molecular immunology; Vol 58(2). 2014 Apr.
• 1. Domm W
  2. Brewer M
  3. Baker SF
  4. Feng C
  5. Martínez-Sobrido L
  6. Treanor J
  7. Dewhurst S
  Use of bacteriophage particles displaying influenza virus hemagglutinin for the detection of hemagglutination-inhibition antibodies.; Journal of virological methods; Vol 197. 2014 Mar.
• 1. Lewis CA
  2. Dewhurst S
  3. McMahon JM
  4. Bunce CA
  5. Keefer MC
  6. Alio AP
  Theoretical model of critical issues in informed consent in HIV vaccine trials.; AIDS care; Vol 26(11). 2014.
• 1. Rhoo KH
  2. Granger M
  3. Sur J
  4. Feng C
  5. Gelbard HA
  6. Dewhurst S
  7. Polesskaya O
  Pharmacologic Inhibition of MLK3 Kinase Activity Blocks the In Vitro Migratory Capacity of Breast Cancer Cells but Has No Effect on Breast Cancer Brain Metastasis in a Mouse Xenograft Model.; PloS one; Vol 9(9). 2014.
• 1. Easterhoff D
  2. DiMaio JT
  3. Liyanage W
  4. Lo CW
  5. Bae W
  6. Doran TM
  7. Smrcka A
  8. Nilsson BL
  9. Dewhurst S
  Fluorescence detection of cationic amyloid fibrils in human semen.; Bioorganic & medicinal chemistry letters; Vol 23(18). 2013 Sep 15.
• 1. Lu N
  2. Silva J
  3. Gu Y
  4. Gerber S
  5. Wu H
  6. Gelbard H
  7. Dewhurst S
  8. Miao H
  Directional Histogram Ratio at Random Probes: A Local Thresholding Criterion for Capillary Images.; Pattern recognition; Vol 46(7). 2013 Jul 01.
• 1. Marker DF
  2. Tremblay MÈ
  3. Puccini JM
  4. Barbieri J
  5. Gantz Marker MA
  6. Loweth CJ
  7. Muly EC
  8. Lu SM
  9. Goodfellow VS
  10. Dewhurst S
  11. Gelbard HA
  The new small-molecule mixed-lineage kinase 3 inhibitor URMC-099 is neuroprotective and anti-inflammatory in models of human immunodeficiency virus-associated neurocognitive disorders.; The Journal of neuroscience : the official journal of the Society for Neuroscience; Vol 33(24). 2013 Jun 12.
• 1. Ma Q
  2. Gelbard HA
  3. Maggirwar SB
  4. Dewhurst S
  5. Gendelman HE
  6. Peterson DR
  7. DiFrancesco R
  8. Hochreiter JS
  9. Morse GD
  10. Schifitto G
  Pharmacokinetic interactions of CEP-1347 and atazanavir in HIV-infected patients.; Journal of neurovirology; Vol 19(3). 2013 Jun.
• 1. Arany S
  2. Benoit DS
  3. Dewhurst S
  4. Ovitt CE
  Nanoparticle-mediated gene silencing confers radioprotection to salivary glands in vivo.; Molecular therapy : the journal of the American Society of Gene Therapy; Vol 21(6). 2013 Jun.
• 1. Easterhoff D
  2. Ontiveros F
  3. Brooks LR
  4. Kim Y
  5. Ross B
  6. Silva JN
  7. Olsen JS
  8. Feng C
  9. Hardy DJ
  10. Dunman PM
  11. Dewhurst S
  Semen-derived enhancer of viral infection (SEVI) binds bacteria, enhances bacterial phagocytosis by macrophages, and can protect against vaginal infection by a sexually transmitted bacterial pathogen.; Antimicrobial agents and chemotherapy; Vol 57(6). 2013 Jun.
• 1. Sullivan MA
  2. Brooks LR
  3. Weidenborner P
  4. Domm W
  5. Mattiacio J
  6. Xu Q
  7. Tiberio M
  8. Wentworth T
  9. Kobie J
  10. Bryk P
  11. Zheng B
  12. Murphy M
  13. Sanz I
  14. Dewhurst S
  Anti-idiotypic monobodies derived from a fibronectin scaffold.; Biochemistry; Vol 52(10). 2013 Mar 12.
• 1. Alcéna DC
  2. Kobie JJ
  3. Kaminski DA
  4. Rosenberg AF
  5. Mattiacio JL
  6. Brewer M
  7. Dewhurst S
  8. Dykes C
  9. Jin X
  10. Keefer MC
  11. Sanz I
  9G4+ antibodies isolated from HIV-infected patients neutralize HIV-1 and have distinct autoreactivity profiles.; PloS one; Vol 8(12). 2013.